Status:
COMPLETED
Protective Effects of RIC in Elderly With Acute Ischemic Stroke Complicating Acute Coronary Syndrome
Lead Sponsor:
Capital Medical University
Conditions:
Elderly Patients
Acute Ischemic Stroke
Eligibility:
All Genders
60+ years
Phase:
NA
Brief Summary
Remote ischemic conditioning (RIC) is a noninvasive strategy in which one or more cycles of brief and transient limb ischemia confers protection against prolonged and severe ischemia in distant organs...
Detailed Description
Remote ischemic conditioning (RIC) is a noninvasive strategy in which one or more cycles of brief and transient limb ischemia confers protection against prolonged and severe ischemia in distant organs...
Eligibility Criteria
Inclusion
- age≥60yo
- AIS within 24 hours after symptom onset which meet the diagnostic criteria for acute ischemic stroke of the 2013th ASA guidelines, AIS was defined as a clinical episode of neurological dysfunction caused by focal cerebral infarction that can be detected on imaging(e.g.,computed tomography or magnetic resonance imaging of head)
- ACS within 24 hours of stroke onset , and ACS contains ST-segment elevation myocardial infarction, non-ST-elevation myocardial infarction, unstable angina and it was defined when there is a rise and/or fall of plasma cardiac biomarkers (e.g., myocardial enzyme，cardiac troponin I), along with supportive evidence in the form of typical symptoms (e.g., chest pain), suggestive electrocardiographic changes, or imaging evidence of new loss of viable myocardium or new regional wall motion abnormality
- The patients missed the opportunity of or contradicted to reperfusion therapy (i.e., intravenous thrombolysis and endovascular treatments) for both AIS and ACS.
- Informed consent obtained
Exclusion
- Unstable vital signs
- Prior ipsilateral stroke with residual deficits
- AIS caused by cardioembolism, suspicious arterial dissection, intracranial sinus thrombolysis, vasculitis, and moyamoya disease.
- Intracranial bleeding.
- Advanced malignancy.
- Uncontrolled hypertension (defined as systolic blood pressure ≥200 mm Hg despite medications at enrollment).
- Any vascular, soft tissue, or orthopedic injury (eg, superficial wounds and fractures of the arm) that contraindicated bilateral arm ischemic preconditioning.
- Peripheral vascular disease that affecting the upper limbs' arteries
- Any disorder that could potentially increase pre-stroke myocardial enzyme concentrations (eg, percutaneous coronary intervention or myocardial infarction within the previous 6 weeks)
- Coronary artery stenosis requiring coronary bypass surgery for the index event within 3 months; or severe heart failure requiring mechanical ventilation or use of an intra-aortic balloon pump
- Taking drugs in the study period or are participating in other clinical trials.
- Severe psychiatric disease.
- Patients who cannot keep treatment or follow-up.
Key Trial Info
Start Date :
March 10 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2022
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT03868007
Start Date
March 10 2019
End Date
April 10 2022
Last Update
November 29 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital, Capital Medical University
Beijing, Beijing Municipality, China, 100053